K2 HealthVentures Equity Trust LLC 13D and 13G filings for ASLAN Pharmaceuticals Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-20 5:20 pm Purchase |
2023-02-24 | 13G | ASLAN Pharmaceuticals Limited ASLN |
K2 HealthVentures Equity Trust LLC | 3,308,266 6.200% |
3,308,266 (New Position) |
Filing |